@article{c79ec04f1d4b4d9dbb88080a42eb5a2a,
title = "Changing the course: Equity effects and institutional risk amid policy shift in higher education financing in Kenya",
abstract = "Reform in higher education financing in Kenya has been occasioned by both endogenous and exogenous variables. Internal pressures of a declining economy, rapid demographic growth and increased inter-and intra-sectoral competition for scare financial resources, couple with external neo-liberal doctrine championed by global donors like the World Bank have resulted in a new market-competitive policy of financing higher education. This paper analyzes the equity and risk effects of the new policy for the main stakeholders, namely students, academics and institutions themselves. The paper contends that the policy shift has had a significant effect on equity just as it has introduced universities to risks through engagement in academic capitalism with its emphasis on marketization of university programs and services. The paper concludes with suggestions on some policy options that could help to mitigate the negative consequences of this new policy.",
keywords = "Equity, Higher education finance, Higher education policy, Kenya, Market-competitive policy",
author = "Munene, {Ishmael I.} and Wycliffe Otieno",
note = "Funding Information: In 1998 the university entered into a collaborative research partnership with researchers from United Kingdom{\textquoteright}s Oxford University with financial support from the International Aids Vaccine Initiative, funded by the multinational corporation drug manufacturer, Pfizer Pharmaceuticals, to develop an AIDS vaccine from Cytotoxie T Lymphocyte (CTL). This is a type of white blood cells that protects Nairobi{\textquoteright}s commercial sex workers from infection by the killer disease. The research project almost collapsed following serious legal tussle and accusations of deceit after it was discovered that Oxford researchers had patented CTL and the vaccine design in Britain without informing the University of Nairobi researchers or acknowledging their contributions (Gathura 2003; Sihanya 2003). Unaware of the intricacies involved in international collaboration, the University of Nairobi researchers were outwitted and outmaneuvered by their more informed international partners. To this day, the vaccine has yet to be successfully developed and neither has the trust between the two institutions been fully restored. Copyright: Copyright 2014 Elsevier B.V., All rights reserved.",
year = "2008",
month = apr,
doi = "10.1007/s10734-007-9067-3",
language = "English (US)",
volume = "55",
pages = "461--479",
journal = "Higher Education",
issn = "0018-1560",
publisher = "Springer Netherlands",
number = "4",
}